796 related articles for article (PubMed ID: 30982177)
1. A randomized, investigator-blinded, controlled, split-scalp study of the efficacy and safety of a 1550-nm fractional erbium-glass laser, used in combination with topical 5% minoxidil versus 5% minoxidil alone, for the treatment of androgenetic alopecia.
Suchonwanit P; Rojhirunsakool S; Khunkhet S
Lasers Med Sci; 2019 Dec; 34(9):1857-1864. PubMed ID: 30982177
[TBL] [Abstract][Full Text] [Related]
2. Topical 5% minoxidil versus combined erbium YAG laser and topical 5% minoxidil in androgenetic alopecia: A randomized controlled trial.
Mokhtari F; Zavare Z; Iraji F
J Cosmet Dermatol; 2023 Oct; 22(10):2737-2743. PubMed ID: 37574862
[TBL] [Abstract][Full Text] [Related]
3. Investigator-blinded, controlled, and randomized comparative study on 1565 nm non-ablative fractional laser versus 5% minoxidil for treatment of androgenetic alopecia.
Qu H; Zhang R; Xin W; Jing H; Wang G; Gao L
J Cosmet Dermatol; 2024 May; 23(5):1638-1644. PubMed ID: 38247260
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness and safety of the ablative fractional 2940-nm Er: YAG laser for the treatment of androgenetic alopecia.
Dai R; Yang X; Su Y; Wu X
Lasers Med Sci; 2024 May; 39(1):128. PubMed ID: 38724798
[TBL] [Abstract][Full Text] [Related]
5. A randomized, double-blind controlled study of the efficacy and safety of topical solution of 0.25% finasteride admixed with 3% minoxidil vs. 3% minoxidil solution in the treatment of male androgenetic alopecia.
Suchonwanit P; Srisuwanwattana P; Chalermroj N; Khunkhet S
J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2257-2263. PubMed ID: 29972712
[TBL] [Abstract][Full Text] [Related]
6. Treatment of alopecia areata with nonablative fractional laser combined with topical minoxidil.
Wang W; Gegentana ; Tonglaga ; Bagenna ; Li Y
J Cosmet Dermatol; 2019 Aug; 18(4):1009-1013. PubMed ID: 31245963
[TBL] [Abstract][Full Text] [Related]
7. Oral Minoxidil vs Topical Minoxidil for Male Androgenetic Alopecia: A Randomized Clinical Trial.
Penha MA; Miot HA; Kasprzak M; Müller Ramos P
JAMA Dermatol; 2024 Jun; 160(6):600-605. PubMed ID: 38598226
[TBL] [Abstract][Full Text] [Related]
8. A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men.
Olsen EA; Dunlap FE; Funicella T; Koperski JA; Swinehart JM; Tschen EH; Trancik RJ
J Am Acad Dermatol; 2002 Sep; 47(3):377-85. PubMed ID: 12196747
[TBL] [Abstract][Full Text] [Related]
9. Use of topical minoxidil therapy for androgenetic alopecia in women.
Jacobs JP; Szpunar CA; Warner ML
Int J Dermatol; 1993 Oct; 32(10):758-62. PubMed ID: 8225725
[TBL] [Abstract][Full Text] [Related]
10. Non-ablative Er:YAG laser is an effective tool in the treatment arsenal of androgenetic alopecia.
Day D; McCarthy M; Talaber I
J Cosmet Dermatol; 2022 May; 21(5):2056-2063. PubMed ID: 34435735
[TBL] [Abstract][Full Text] [Related]
11. A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss.
Lucky AW; Piacquadio DJ; Ditre CM; Dunlap F; Kantor I; Pandya AG; Savin RC; Tharp MD
J Am Acad Dermatol; 2004 Apr; 50(4):541-53. PubMed ID: 15034503
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of 5% minoxidil versus combined 5% minoxidil and 0.01% tretinoin for male pattern hair loss: a randomized, double-blind, comparative clinical trial.
Shin HS; Won CH; Lee SH; Kwon OS; Kim KH; Eun HC
Am J Clin Dermatol; 2007; 8(5):285-90. PubMed ID: 17902730
[TBL] [Abstract][Full Text] [Related]
13. A pilot split-scalp study of combined fractional radiofrequency microneedling and 5% topical minoxidil in treating male pattern hair loss.
Yu AJ; Luo YJ; Xu XG; Bao LL; Tian T; Li ZX; Dong YX; Li YH
Clin Exp Dermatol; 2018 Oct; 43(7):775-781. PubMed ID: 29952106
[TBL] [Abstract][Full Text] [Related]
14. Androgenetic alopecia: an evidence-based treatment update.
Varothai S; Bergfeld WF
Am J Clin Dermatol; 2014 Jul; 15(3):217-30. PubMed ID: 24848508
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of a new 5% minoxidil formulation in male androgenetic alopecia: A randomized, placebo-controlled, double-blind, noninferiority study.
Blume-Peytavi U; Issiakhem Z; Gautier S; Kottner J; Wigger-Alberti W; Fischer T; Hoffmann R; Tonner F; Bouroubi A; Voisard JJ
J Cosmet Dermatol; 2019 Feb; 18(1):215-220. PubMed ID: 29659116
[TBL] [Abstract][Full Text] [Related]
16. The effect of 1540-nm fractional erbium-glass laser in the treatment of androgenic alopecia.
Alhattab MK; Al Abdullah MJ; Al-Janabi MH; Aljanaby WA; Alwakeel HA
J Cosmet Dermatol; 2020 Apr; 19(4):878-883. PubMed ID: 31524330
[TBL] [Abstract][Full Text] [Related]
17. Multi-therapies in androgenetic alopecia: review and clinical experiences.
Rossi A; Anzalone A; Fortuna MC; Caro G; Garelli V; Pranteda G; Carlesimo M
Dermatol Ther; 2016 Nov; 29(6):424-432. PubMed ID: 27424565
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of 1,550-nm Erbium-Glass Fractional Laser Treatment and Its Effect on the Expression of Insulin-Like Growth Factor 1 and Wnt/β-Catenin in Androgenetic Alopecia.
Meephansan J; Ungpraphakorn N; Ponnikorn S; Suchonwanit P; Poovorawan Y
Dermatol Surg; 2018 Oct; 44(10):1295-1303. PubMed ID: 30096107
[TBL] [Abstract][Full Text] [Related]
19. Comparative Evaluation of the Clinical Efficacy of PRP-Therapy, Minoxidil, and Their Combination with Immunohistochemical Study of the Dynamics of Cell Proliferation in the Treatment of Men with Androgenetic Alopecia.
Pakhomova EE; Smirnova IO
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899959
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of autologous platelet-rich plasma therapy versus topical Minoxidil in men with moderate androgenetic alopecia: a randomized open-label trial.
Balasundaram M; Kumari R; Ramassamy S
J Dermatolog Treat; 2023 Dec; 34(1):2182618. PubMed ID: 36800229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
